Apolipoprotein J/clusterin induction in myocarditis. A localized response gene to myocardial injury

American Journal of Pathology

Volumn 148, Issue 6, 1996, Pages 1971-1983

  Swertfeger, Debi K ^a   Witte, David P ^a   Stuart, William D ^a   Rockman, Howard A ^b   Harmony, Judith A K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART ATRIUM MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; TISSUE REPAIR; VIRUS MYOCARDITIS;

ANIMALS; AUTOIMMUNE DISEASES; CARDIOMEGALY; CLUSTERIN; COMPLEMENT INACTIVATOR PROTEINS; COXSACKIEVIRUS INFECTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROVIRUS B, HUMAN; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HEART VENTRICLES; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR CHAPERONES; MYOCARDITIS; MYOCARDIUM; RNA, MESSENGER;

EID: 0029980188     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Jordan-Starck TC, Witte DP, Aronow BJ, Harmony JAK: Apolipoprotein J: a membrane policeman? Curr Opin Lipidol 1992, 3:75-85
2. Jenne DE, Tschopp J: Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci 1992, 17:154-159
3. Guenette RS, Corbeil HB, Leger J, Wong K, Mezl V, Mooibroeck M, Tenniswood M: Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endocrinol 1994, 12:47-60
4. Rouleau M, Leger J, Tenniswood M: Ductal heterogeneity of cytokeratins, gene expression, and cell death in the rat ventral prostate. Mol Endocrinol 1990, 42003-2013
5. Rosenberg ME, Paller MS: Differential gene expression in the recovery from ischemic renal injury. Kidney Int 1991, 39:1156-1161
6. Correa-Rotter R, Hosteller TH, Manivel JC, Eddy AA, Rosenberg ME: Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int 1992, 41: 938-950
7. May PC, Finch CE: Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci 1992, 15:391-396
8. Lampert-Etchells M, McNeill TH, Laping NJ, Zarow C, Finch CE, May PC: Sulfated glycoprotein-2 is increased in rat hippocampus following entorhinal cortex lesioning. Brain Res 1991, 563:101-106
9. Passinetti GM, Finch CE: Sulfated glycoprotein-2 (SGP-2) mRNA is expressed in rat striatal astrocytes following ibotenic acid lesions. Neurosci Lett 1991, 130:1-4
10. Choi-Miura N-H, Ihara Y, Fukuchi K, Takeda M, Nakano Y, Tobe T, Tomita M: SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol 1992, 83:260-264
11. McGeer PL, Kawamata T, Walker DG: Distribution of clusterin in Alzheimer brain tissue. Brain Res 1992, 579:337-341
12. Wu E, Brosnan CF, Raine CS: SP-40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/ oligodendrocyte interactions. J Neuropathol Exp Neurol 1993, 52:129-134
13. Jordan-Starck TC, Lund SD, Witte DP, Aronow BJ, Ley CA, Stuart WD, Swertfeger DK, Clayton LR, Sells SF, Paigen B, Harmony JAK: Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. J Lipid Res 1994, 35:194-210
14. Witte DP, Aronow BJ, Stauderman ML, Stuart WD, Clay MA, Gruppo RA, Jenkins SH, Harmony JAK: Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol 1993, 143:763-773
15. Aronow BJ, Lund SD, Brown TL, Harmony JAK, Witte DP: Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA 1993, 90:725-729
16. Witte DP, Aronow BJ, Dry JK, Harmony JAK: Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis. Dev Dynam 1994, 201:290-296
17. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J: Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 1991, 266:24613-24620
18. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW: Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987, 139: 3630-3636
19. Shiverick KT, Thomas LL, Alpert NR: Purification of cardiac myosin: application to hypertrophied myocardium. Biochim Biophys Acta 1975, 393:124-133
20. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J, Chien KR: Segregation of atnal-specific and inducibie expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 1991, 88:8277-8281
21. Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross J, Chien KR: Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci USA 1994, 91:2694-2698
22. Brown TL, Moulton BC, Baker VV, Mira J, Harmony JAK: Expression of apolipoprotein J in the uterus is associated with tissue remodeling. Biol Reprod 1995, 52:1038-1049
23. Zivin RA, Condra JH, Dixon RA, Seidah NG, Chretien M, Nemer M, Chamberland M, Drouin J: Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors. Proc Natl Acad Sci USA 1984, 81:6325-6329
24. Witte DP, Wiginton DA, Hutton JJ, Aronow BJ: Coordinate developmental regulation of purine catabolic enzyme expression in gastrointestinal and postimplantation reproductive tracts. J Cell Biol 1991, 115:179-190
25. Sylvester SR, Skinner MK, Griswold MD: A sulfated glycoprotein synthesized by Sertoli cells and by epididymal cells is a component of the sperm membrane. Biol Reprod 1984, 31:1087-1101
26. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
27. van Bilsen M, Chien KR: Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducibie gene expression. Cardiovasc Res 1993, 27:1140-1149
28. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT, Overbeek PA: FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 1991, 88:2065-2069
29. Rose NR, Neumann DA, Herskowitz A: Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopath Res 1988, 7:266-278
30. Traystman MD, Chow LH, McManus BM, Herskowitz A, Nesbitt MN, Beisel KW: Susceptibility to coxsackievirus B3-induced chronic myocarditis maps near the murine Tcr-α and Myhc-α loci on chromosome 14. Am J Pathol 1991, 138:721-726
31. Huber SA, Lodge PA: Coxsackievirus B-3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. Am J Pathol 1984, 116:21-29
32. Huber SA, Lodge PA: Coxsackie virus B-3 myocarditis: identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 1986, 122:284-291
33. Woodruff JF: Viral myocarditis. Am J Path 1980, 101: 426-479
34. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992, 359: 693-699
35. Rockman HA, Wachhorst SP, Mao L, Ross J: ANGII receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 1994, 266:H2468-H2475
36. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P-Y, Sawczuk IS: Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol Cell Biol 1989, 9:3473-3481
37. Sawczuk IS, Hoke G, Olsson CA, Conner J, Buttyan R: Gene expression in response to acute unilateral ureteral obstruction. Kidney Int 1989, 35:1315-1319
38. Rozovsky I, Morgan TE, Willoughby DA, Dugich-Djordjevich MM, Pasinetti GM, Johnson SA, Finch CE: Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 1994, 62:741-758
39. Frank MM: Complement in the pathophysiology of human disease. N Engl J Med 1987, 316:1525-1530
40. Crawford MH, Grover FL, Kolb WP, McMahan CA, O'Rourke RA, McManus LM, Pinckard RN: Complement and neutrophil activation in the pathogenesis of the ischemic myocardial injury. Circulation 1988, 78: 1449-1458
41. Couser WB, Baker PJ, Adler S: Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int 1985, 28:879-890
42. Choi N-H, Mazda T, Tomita M: A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol Immunol 1989, 26:835-840
43. Murphy BF, Kirszbaum L, Walker ID, d'Apice AJF: SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in immune deposits in glomerulonephritis. J Clin Invest 1988, 81:1858-1864
44. Saunders JR, Aminian A, McRae JL, O'Farrell KA, Adam WR, Murphy BF: Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 1994, 45:817-827
45. Vakeva A, Laurila P, Meri S: Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Immunology 1993, 80:177-182
46. Altman PL, Katz DD: Inbred and genetically defined strains of laboratory animals. Part I. Mouse and Rat. Edited by PL Altman, DD Katz. Bethesda, MD, Fed Am Soc Exp Biol, 1979, p 21
47. Nath KA, Dvergsten J, Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME: Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury. Lab Invest 1994, 71: 209-218
48. Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, Strickland DK, Argraves WS: Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J Biol Chem 1995, 270: 13070-13075
49. Saito A, Pietromonaco S, Loo AK-C, Farquhar MG: Complete cloning and sequencing of rat gp330/ "megalin", a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 1994, 91:9725-9729
50. Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J: Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 1992, 267:26172-26180
51. Moestrup SK Nielsen S, Andreasen P, Jørgensen KE, Nykjaer A, Roigaard H, Gliemann J, Christensen EI: Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J Biol Chem 1993, 268:16564-16570
52. Zinsser HH, Pryde AW: Experimental study of physical factors including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog. Ann Surg 1952, 136:818-827
53. McRitchie DI, Girotti MJ, Glynn MFX, Goldberg JM, Rotstein OD: Effect of systemic fibrinogen depletion on intraabdominal abscess formation. J Lab Clin Med 1991, 118:48-55
54. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL: Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991, 18:1617-1626
55. Bishop SP, Melsen LR: Myocardial necrosis, fibrosis, and DNA synthesis in experimental cardiac hypertrophy induced by sudden pressure overload. Circ Res 1976, 39:238-245
56. Contard F, Koteliansky V, Marotte F, Dubus I, Rappaport L, Samuel JL: Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. Lab Invest 1991, 64:65-75